Mental Health Clinics in Globe, AZ Accepting Medicare
5 Mental Health Clinics found. Showing 1 - 5
 Horizon Human Services, Inc. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1100 N Broad St, Suite A, Globe, AZ 85501 Phone: 928-402-8032 Fax: 928-402-9099 |
Horizon Health And Wellness, Inc. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 415 W Baseline Spurs, Globe, AZ 85501 Phone: 928-402-9297 Fax: 928-402-9414 |
Integrated Counseling Services, Pllc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1450 S South St Ste 2, Globe, AZ 85501 Phone: 928-402-0013 Fax: 928-402-0015 |
Nazcare, Inc - Care Wellness Center Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 996 N Broad St, Suite 6, Globe, AZ 85501 Phone: 928-442-9205 |
Red Willow Counseling Pllc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 285 N Broad St, Globe, AZ 85501 Phone: 928-961-4774 |
News Archive
Health policy researcher calls for orthopaedic surgeons to implement principles of value-based healthcare
Healthcare expenditures currently account for 18% of the United States Gross Domestic Product (GDP). Some experts have suggested that an emphasis on value may be an effective strategy to evaluate healthcare costs.
ArQule announces presentations on ARQ 197 c-Met inhibitor at 2010 ASCO
ArQule, Inc. today announced that the following presentations of clinical data for ARQ 197, a selective inhibitor of the c-Met receptor tyrosine kinase, will take place at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held June 4-8, 2010 in Chicago, Illinois.
New studies explore risk factors and public health concerns over coronavirus
Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response. JACEP Open, a new official open access journal of the American College of Emergency Physicians (ACEP), explores coronavirus (COVID-19) concerns in two new analyses.
Senate measure would allow generic versions of biotechnology drugs after five years
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
› Verified 3 days ago